All
FDA Approves Xpovio to Treat Relapsed/Refractory Multiple Myeloma
July 3rd 2019The Food and Drug Administration has granted an accelerated approval to Xpovio in combination with dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma who have received more than four prior therapies.
Cancer: It's Never An Easy Journey
July 2nd 2019Cancer doesn’t discriminate. It doesn’t care what race, gender, ethnicity, sexuality or even age you are. It takes no prisoners. And it certainly did not take me. I continue to remain resilient despite what I’ve been through and despite what still may be on the horizon.
Divided In Our Anatomy, United By Our Ferocity
June 28th 2019Breast cancer affects both men and women, yet there continues to be a "separation of power" when it comes to research and development of the methods by which to treat breast cancer. I think the greatest hope for men to come out of the shadow of breast cancer in a very pink world is through the support of women.
FDA Approves Zirabev, an Avastin Biosimilar, for Five Cancer Types
June 28th 2019The FDA has approved Zirabev, a biosimilar to Avastin, for the treatment of five types of cancer: colorectal cancer; non-small cell lung cancer; glioblastoma; metastatic renal cell carcinoma; and persistent, recurrent or metastatic cervical cancer.
Breast Implant-Associated Lymphoma: Do I Need to be Concerned?
June 27th 2019Women who undergo a mastectomy have many options and concerns to consider when undergoing breast reconstruction. My choice was simple: I wanted to look as natural as possible, but I have since learned that I have textured implants.